PMC:7102591 / 17105-17414 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"512","span":{"begin":145,"end":150},"obj":"Gene"},{"id":"524","span":{"begin":172,"end":184},"obj":"Chemical"},{"id":"525","span":{"begin":189,"end":199},"obj":"Chemical"}],"attributes":[{"id":"A512","pred":"tao:has_database_id","subj":"512","obj":"Gene:3716"},{"id":"A524","pred":"tao:has_database_id","subj":"524","obj":"MESH:C000613732"},{"id":"A525","pred":"tao:has_database_id","subj":"525","obj":"MESH:C584571"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ssociated with increased HZV risk, whereas vaccination was associated with a lower risk [71]. More recent reports from RCTs conducted with novel JAK-1 selective inhibitors upadacitinib and filgotinib have basically confirmed the same trend, suggesting that the increase in HZV infections can be considered as "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T207","span":{"begin":277,"end":287},"obj":"Disease"}],"attributes":[{"id":"A207","pred":"mondo_id","subj":"T207","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ssociated with increased HZV risk, whereas vaccination was associated with a lower risk [71]. More recent reports from RCTs conducted with novel JAK-1 selective inhibitors upadacitinib and filgotinib have basically confirmed the same trend, suggesting that the increase in HZV infections can be considered as "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T119","span":{"begin":75,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T120","span":{"begin":89,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"}],"text":"ssociated with increased HZV risk, whereas vaccination was associated with a lower risk [71]. More recent reports from RCTs conducted with novel JAK-1 selective inhibitors upadacitinib and filgotinib have basically confirmed the same trend, suggesting that the increase in HZV infections can be considered as "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T128","span":{"begin":161,"end":171},"obj":"Chemical"}],"attributes":[{"id":"A128","pred":"chebi_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"ssociated with increased HZV risk, whereas vaccination was associated with a lower risk [71]. More recent reports from RCTs conducted with novel JAK-1 selective inhibitors upadacitinib and filgotinib have basically confirmed the same trend, suggesting that the increase in HZV infections can be considered as "}

{"project":"2_test","denotations":[{"id":"32205186-30183607-4826906","span":{"begin":89,"end":91},"obj":"30183607"}],"text":"ssociated with increased HZV risk, whereas vaccination was associated with a lower risk [71]. More recent reports from RCTs conducted with novel JAK-1 selective inhibitors upadacitinib and filgotinib have basically confirmed the same trend, suggesting that the increase in HZV infections can be considered as "}